Sotera Health CO Form 4 insider transactions

Director Ann R. Klee reports the acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co.

Director David Donnini acquired 20,089 Restricted Stock Units (RSUs) in Sotera Health Co on May 24, 2024.

Director Sean Cunningham reports acquisition of restricted stock units and disposal of common stock.

Director Chen Ruoxi reports acquiring 20,089 Restricted Stock Units (RSUs) and disposing of 20,089 shares of Common Stock.

Warburg Pincus entities sold 16,594,363 shares of Sotera Health Co in a public secondary offering on March 4, 2024, at a price of $14.3075 per share.

Warburg Pincus & Co. and affiliated entities sold 16,594,363 shares of Sotera Health Co. in a public secondary offering on March 4, 2024.

GTCR Investment XI LLC and affiliated entities sold 11,062,908 shares of Sotera Health Co (SHC) in an underwritten public secondary offering at $14.3075 per share.

Jonathan M. Lyons, CFO of Sotera Health Co., reports the acquisition of restricted stock units and stock options, as well as holdings of existing RSUs.

Alexander Dimitrief, SVP, General Counsel and Secretary of Sotera Health Co., reports the acquisition of restricted stock units and stock options.

Director Ann R. Klee sold 5,750 shares of Sotera Health (SHC) at $14.3075 per share as part of a public secondary offering.

Michael Rutz, President of Sterigenics (Sotera Health Co), reports acquisition and disposal of shares and stock options, including sales in a public secondary offering.

Sotera Health's CEO, Michael B. Petras Jr., reports the acquisition and disposal of company stock, including transactions related to vesting of restricted stock units (RSUs) and an underwritten public secondary offering.